Trial Information
Inclusion Criteria:
- Patients suitable for surgery with confirmed prostate cancer, Gleason grade ≥ 3
- Patient has received no prior treatment for prostate cancer.
- Patient has adequate renal function: Estimated creatinine clearance ≥ 60 ml/minute.
- Patient must sign written informed consent according to the protocol approved by the
Regional Ethics Committee.
Exclusion Criteria:
- Patient with contraindication to MR or MR contrast media according to clinical
practice.
- Patients who want to withdraw for any reason during the study.
- Patients previously undergone pelvic surgery or radiation therapy
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Authority:
Norway:National Committee for Medical and Health Research Ethics
Study ID:
REK-2010/1656
NCT ID:
NCT01464216
Start Date:
October 2011
Completion Date:
Related Keywords:
- Prostatic Neoplasms
- Genital Neoplasms, Male
- Prostatic Diseases
- Functional Magnetic Resonance Imaging
- Prostate cancer
- Neoplasms
- Genital Neoplasms, Male
- Prostatic Diseases
- Prostatic Neoplasms